Korean J Dermatol.  2013 Nov;51(11):871-877.

Cyclosporine Stimulates the Expression of CDK4 through NFATc1 Suppression: Anagen Phase Hair Induction

Affiliations
  • 1Department of Dermatology, Sorokdo National Hospital, Goheung, Korea.
  • 2Department of Dermatology, College of Medicine, Dong-A University, Busan, Korea. khkim@dau.ac.kr
  • 3Department of Dermatology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

Abstract

BACKGROUND
Hair growth is spontaneously activated from quiescent bulge stem cells or is activated from precocious anagen. Upon spontaneous activation of hair growth or activation induced by nuclear factor of activated T cells c1 (NFATc1) inhibitors, NFATc1 expression is lost and cyclin dependent kinase (CDK4) repression is relieved.
OBJECTIVE
The purpose of this study was to investigate the mechanisms of cyclosporine as a hair cycle regulator in the treatment of Alopecia areata (AA).
METHODS
In this study, we planned to investigate the hair growing properties of cyclosporine in vitro conditions. Briefly, the effects of different concentrations of cyclosporine (200, 500, 1,000, 2,000 mmol) on the growth of cultured hair follicles were examined through the expression of NFATc1 and CDK4.
RESULTS
NFATc1 was downregulated and CDK4 expression was upregulated especially in the bulge areas, outer root sheath and hair bulb matrix cells as the concentration of cyclosporine increased.
CONCLUSION
Cyclosporine induces CDK4 expression by NFATc1 suppression, which acts to relieve repressed CDK4, resulting in hair growth. In conclusion, cyclosporine is one of the candidates as a therapeutic agent for the treatment of hair loss.

Keyword

CDK4; Cyclosporine; NFATc1

MeSH Terms

Alopecia Areata
Cyclins
Cyclosporine*
Hair Follicle
Hair*
Phosphotransferases
Repression, Psychology
Stem Cells
T-Lymphocytes
Cyclins
Cyclosporine
Phosphotransferases
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr